BACKGROUND: Social support has been found to be protective from adverse health effects of psychological stress. We hypothesized that higher social support would predict a more favorable course of Crohn's disease (CD) directly (main effect hypothesis) and via moderating other prognostic factors (buffer hypothesis). METHODS: Within a multicenter cohort study we observed 597 adults with CD for 18 months. We assessed social support using the ENRICHD Social Support Inventory. Flares, nonresponse to therapy, complications, and extraintestinal manifestations were recorded as a combined endpoint indicating disease deterioration. We controlled for several demographic, psychosocial, and clinical variables of potential prognostic importance. We used multivariate binary logistic regression to estimate the overall effect of social support on the odds of disease deterioration and to explore main and moderator effects of social support by probing interactions with other predictors. RESULTS: The odds of disease deterioration decreased by 1.5 times (95% confidence interval [CI]: 1.2-1.9) for an increase of one standard deviation (SD) of social support. In case of low body mass index (BMI) (i.e., 1 SD below the mean or <19 kg/m(2) ), the odds decreased by 1.8 times for an increase of 1 SD of social support. In case of low social support, the odds increased by 2.1 times for a decrease of 1 SD of BMI. Low BMI was not predictive under high social support. CONCLUSIONS: The findings suggest that elevated social support may favorably affect the clinical course of CD, particularly in patients with low BMI.
BACKGROUND: Social support has been found to be protective from adverse health effects of psychological stress. We hypothesized that higher social support would predict a more favorable course of Crohn's disease (CD) directly (main effect hypothesis) and via moderating other prognostic factors (buffer hypothesis). METHODS: Within a multicenter cohort study we observed 597 adults with CD for 18 months. We assessed social support using the ENRICHD Social Support Inventory. Flares, nonresponse to therapy, complications, and extraintestinal manifestations were recorded as a combined endpoint indicating disease deterioration. We controlled for several demographic, psychosocial, and clinical variables of potential prognostic importance. We used multivariate binary logistic regression to estimate the overall effect of social support on the odds of disease deterioration and to explore main and moderator effects of social support by probing interactions with other predictors. RESULTS: The odds of disease deterioration decreased by 1.5 times (95% confidence interval [CI]: 1.2-1.9) for an increase of one standard deviation (SD) of social support. In case of low body mass index (BMI) (i.e., 1 SD below the mean or <19 kg/m(2) ), the odds decreased by 1.8 times for an increase of 1 SD of social support. In case of low social support, the odds increased by 2.1 times for a decrease of 1 SD of BMI. Low BMI was not predictive under high social support. CONCLUSIONS: The findings suggest that elevated social support may favorably affect the clinical course of CD, particularly in patients with low BMI.
Authors: Kimberly L D'Anna-Hernandez; Maria Camille Hoffman; Gary O Zerbe; Mary Coussons-Read; Randal G Ross; Mark L Laudenslager Journal: Psychosom Med Date: 2012-02-24 Impact factor: 4.312
Authors: Stefan Begré; Benjamin Misselwitz; Sebastian Bruno Ulrich Jordi; Brian Matthew Lang; Jacqueline Wyss; Bianca Auschra; Bahtiyar Yilmaz; Niklas Krupka; Thomas Greuter; Philipp Schreiner; Luc Biedermann; Martin Preisig; Roland von Känel; Gerhard Rogler Journal: J Gastroenterol Date: 2022-07-28 Impact factor: 6.772
Authors: Valérie Pittet; Carla Vaucher; Florian Froehlich; Bernard Burnand; Pierre Michetti; Michel H Maillard Journal: PLoS One Date: 2017-02-10 Impact factor: 3.240
Authors: Vera E R Asscher; Felicia V Y Lee-Kong; Esther D Kort; Floor J van Deudekom; Simon P Mooijaart; P W Jeroen Maljaars Journal: J Crohns Colitis Date: 2019-10-28 Impact factor: 9.071
Authors: Roland von Känel; Rebecca E Meister-Langraf; Jürgen Barth; Hansjörg Znoj; Jean-Paul Schmid; Ulrich Schnyder; Mary Princip Journal: J Clin Med Date: 2022-04-02 Impact factor: 4.241